spironolactone has been researched along with ramipril in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.57) | 18.2507 |
| 2000's | 8 (28.57) | 29.6817 |
| 2010's | 16 (57.14) | 24.3611 |
| 2020's | 3 (10.71) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Castro, P; Chávez, A; Chávez, E; Corbalán, R; Godoy, I; Quintana, JC; Rodríguez, JA; Yovanovich, J | 1 |
| Azpitarte Almagro, J | 1 |
| Redfield, MM | 1 |
| Majumdar, SR; McAlister, FA; Soumerai, SB | 1 |
| Aviram, M; Coleman, R; Hamoud, S; Hayek, T; Kaplan, M; Keidar, S; Pavlotzky, E | 1 |
| Cohen-Solal, A; Dietz, R; Eichhorn, E; Erhardt, L; Hobbs, FD; Krum, H; Maggioni, A; McKelvie, RS; McMurray, J; Piña, IL; Soler-Soler, J; Swedberg, K | 1 |
| Asseman, P; Bauters, C; Darchis, J; De Groote, P; Ennezat, PV; Gonin, X; Lamblin, N; Lejemtel, T | 1 |
| Barfod, T; Klit, J; Rasmussen, ZZ | 1 |
| Dabrowski, R; Pedzich-Placha, E | 1 |
| Cheva, A; Kallaras, K; Karkavelas, G; Mavrakanas, TA; Mironidou-Tzouveleki, M | 1 |
| Schröder, S; Strobel, J | 1 |
| Billings, FT; Brown, NJ; Byrne, JG; Ikizler, TA; Mercaldo, ND; Pretorius, M; Schildcrout, JS | 1 |
| Azizi, M; Bobrie, G; Boutouyrie, P; Chatellier, G; Frank, M; Laurent, S; Menard, J; Peyrard, S; Plouin, PF | 1 |
| Mancia, G | 1 |
| Ball, SK; Billings, FT; Body, SC; Brown, NJ; Byrne, JG; Greelish, JP; Hoff, SJ; Mishra, V; Murray, KT; Petracek, MR; Pretorius, M; Yu, C | 1 |
| Stafford-Smith, M | 1 |
| Akpek, M; Kaya, EG; Kaya, MG; Lam, YY; Sarli, B; Topsakal, R | 1 |
| Bhadada, SV; Patel, BM | 1 |
| Li, L; Liu, LM; Tan, LL; Zhao, HL | 1 |
| Azizi, M; Bobrie, G; Chatellier, G; Frank, M; Ménard, J; Perdrix, L; Plouin, PF | 1 |
| Franken, PR; Woltersdorf, R | 1 |
| Balogh, DB; Fekete, A; Genovese, F; Hodrea, J; Hosszu, A; Koszegi, S; Lakat, T; Lenart, L; Molnar, A; Sparding, N; Szabo, AJ; Szkibinszkij, E; Vannay, A; Wagner, L | 1 |
| Balogh, DB; Fekete, A; Hodrea, J; Hosszu, A; Lakat, T; Lenart, L; Molnar, A; Szabo, AJ | 1 |
| Kassie, GM; Kerr, M; Moffat, A; Pratt, N; Roughead, EE | 1 |
| Alcalai, R; Arad, M; Guetta, T; Hochhauser, E; Kornowski, R; Ofek, E; Petrover, Z; Seidman, CE; Seidman, J; Yadin, D | 1 |
1 review(s) available for spironolactone and ramipril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 trial(s) available for spironolactone and ramipril
| Article | Year |
|---|---|
[Effects of ramipril and spironolactone on ventricular remodeling after acute myocardial infarction: randomized and double-blind study].
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Disease-Free Survival; Double-Blind Method; Female; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Ramipril; Spironolactone; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Function, Left | 1997 |
Sequential nephron blockade versus sequential renin-angiotensin system blockade in resistant hypertension: a prospective, randomized, open blinded endpoint study.
Topics: Adolescent; Adult; Aged; Amiloride; Angiotensin-Converting Enzyme Inhibitors; Biological Transport; Bisoprolol; Blood Pressure; Drug Resistance; Drug Therapy, Combination; Female; Furosemide; Humans; Hypertension; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Nephrons; Prospective Studies; Ramipril; Renin-Angiotensin System; Spironolactone; Young Adult | 2012 |
Angiotensin-converting enzyme inhibition or mineralocorticoid receptor blockade do not affect prevalence of atrial fibrillation in patients undergoing cardiac surgery.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Blood Pressure; Cardiac Surgical Procedures; Double-Blind Method; Electrocardiography; Female; Hospitals, University; Humans; Male; Middle Aged; Ramipril; Receptors, Mineralocorticoid; Renin-Angiotensin System; Spironolactone | 2012 |
Tenascin-C as predictor of left ventricular remodeling and mortality in patients with dilated cardiomyopathy.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Drug Therapy, Combination; Echocardiography; Female; Furosemide; Heart Function Tests; Hong Kong; Humans; Male; Predictive Value of Tests; Prognosis; Propanolamines; Ramipril; Spironolactone; Survival Rate; Tenascin; Tetrazoles; Turkey; Ventricular Remodeling | 2013 |
Greater efficacy of aldosterone blockade and diuretic reinforcement vs. dual renin-angiotensin blockade for left ventricular mass regression in patients with resistant hypertension.
Topics: Adolescent; Adult; Aged; Aldosterone; Amiloride; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Bisoprolol; Blood Pressure; Blood Pressure Determination; Diuretics; Drug Therapy, Combination; Female; Furosemide; Humans; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Ramipril; Renin; Renin-Angiotensin System; Spironolactone; Tetrazoles; Young Adult | 2014 |
22 other study(ies) available for spironolactone and ramipril
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Results of the RALES trial: good news for patients with heart failure and ... for health administrations].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Double-Blind Method; Drug Costs; Economics, Pharmaceutical; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Multicenter Studies as Topic; Placebos; Prognosis; Ramipril; Randomized Controlled Trials as Topic; Spironolactone; Time Factors | 2000 |
Epidemiology and pathophysiology of heart failure.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Disease Progression; Heart Failure; Humans; Incidence; Pulse; Ramipril; Spironolactone; Survival Analysis; Ventricular Function, Left | 2000 |
Synergy between publication and promotion: comparing adoption of new evidence in Canada and the United States.
Topics: Advertising; Angiotensin-Converting Enzyme Inhibitors; Drug Prescriptions; Drug Utilization; Evidence-Based Medicine; Humans; Longitudinal Studies; Practice Patterns, Physicians'; Ramipril; Randomized Controlled Trials as Topic; Spironolactone | 2003 |
Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Cell Line; Enzyme Induction; Eplerenone; Hormone Antagonists; Humans; Lipid Peroxidation; Lipoproteins, LDL; Losartan; Macrophages, Peritoneal; Membrane Proteins; Mice; Mice, Knockout; Mineralocorticoid Receptor Antagonists; NADPH Oxidases; Oxidative Stress; Peptidyl-Dipeptidase A; Phosphoproteins; Protein Transport; Ramipril; Receptor, Angiotensin, Type 1; Receptors, Mineralocorticoid; RNA, Messenger; Spironolactone; Superoxides | 2004 |
Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzopyrans; Biphenyl Compounds; Bisoprolol; Captopril; Carbazoles; Carvedilol; Drug Therapy, Combination; Enalapril; Ethanolamines; Evidence-Based Medicine; Guideline Adherence; Heart Failure; Humans; Indoles; Lisinopril; Metoprolol; Mineralocorticoid Receptor Antagonists; Nebivolol; Practice Guidelines as Topic; Propanolamines; Ramipril; Spironolactone; Stroke Volume; Tetrazoles; Valine; Valsartan | 2005 |
Delayed recovery of left ventricular systolic dysfunction: ''give time to medical therapy''.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Diuretics; Drug Therapy, Combination; Female; Furosemide; Humans; Middle Aged; Ramipril; Spironolactone; Treatment Outcome; Ventricular Dysfunction, Left | 2007 |
[Renal effect of treatment for heart failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathies; Diuretics; Furosemide; Heart Failure; Humans; Kidney; Male; Metolazone; Middle Aged; Ramipril; Spironolactone; Uremia | 2009 |
[Improvement of left ventricular function during combined carvedilol, ramipril and spironolactone therapy after myocarditis in patient treated earlier by chemotherapy due to Hodgkin's lymphoma - 3-years follow-up].
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Carvedilol; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; Mineralocorticoid Receptor Antagonists; Myocarditis; Propanolamines; Ramipril; Spironolactone; Ventricular Dysfunction, Left; Ventricular Function, Left | 2010 |
Effect of ramipril alone compared to ramipril with eplerenone on diabetic nephropathy in streptozocin-induced diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Therapy, Combination; Eplerenone; Glomerular Mesangium; Hypertrophy; Kidney Glomerulus; Male; Mineralocorticoid Receptor Antagonists; Proteinuria; Ramipril; Random Allocation; Rats; Rats, Wistar; Severity of Illness Index; Spironolactone | 2010 |
[Postpartum cardiomyopathy].
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Antihypertensive Agents; Bisoprolol; Bromocriptine; Cardiomyopathies; Female; Heparin, Low-Molecular-Weight; Humans; Mineralocorticoid Receptor Antagonists; Postpartum Period; Radiography; Ramipril; Risk Factors; Spironolactone; Sulfonamides; Torsemide; Treatment Outcome | 2011 |
Obesity and oxidative stress predict AKI after cardiac surgery.
Topics: Acute Kidney Injury; Aged; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Body Mass Index; Cardiac Surgical Procedures; Diuretics; F2-Isoprostanes; Female; Humans; Interleukin-6; Male; Middle Aged; Obesity; Oxidative Stress; Plasminogen Activator Inhibitor 1; Postoperative Complications; Ramipril; Randomized Controlled Trials as Topic; Risk Factors; Signal Transduction; Spironolactone | 2012 |
Additional drug treatment in resistant hypertension: need for randomized studies.
Topics: Angiotensin-Converting Enzyme Inhibitors; Female; Humans; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Nephrons; Ramipril; Renin-Angiotensin System; Spironolactone | 2012 |
Precardiac surgery angiotensin-converting enzymes and mineralocorticoid blockers do not trump atrial fibrillation but possibly acute kidney injury: the value of a negative randomized study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Cardiac Surgical Procedures; Female; Humans; Male; Ramipril; Receptors, Mineralocorticoid; Spironolactone | 2012 |
Type 2 diabetes-induced cardiovascular complications: comparative evaluation of spironolactone, atenolol, metoprolol, ramipril and perindopril.
Topics: Animals; Animals, Newborn; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Metoprolol; Perindopril; Ramipril; Rats, Wistar; Spironolactone | 2014 |
[Effect of RAAS antagonist on the expression of gap junction cx43 in myocardium of spontaneously hypertensive rat].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Connexin 43; Eplerenone; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Ramipril; Rats; Rats, Inbred SHR; Rats, Wistar; Renin-Angiotensin System; Spironolactone; Telmisartan | 2013 |
Risk of renal dysfunction in an elderly patient with chronic heart failure.
Topics: Aged, 80 and over; Atrial Fibrillation; Carbazoles; Carvedilol; Diclofenac; Digoxin; Drug Interactions; Drug Therapy, Combination; Female; Heart Failure; Humans; Hypertension; Kidney Failure, Chronic; Myocardial Infarction; Potassium; Potentially Inappropriate Medication List; Propanolamines; Ramipril; Risk Factors; Spironolactone | 2016 |
RAAS inhibitors directly reduce diabetes-induced renal fibrosis via growth factor inhibition.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Line; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epithelial Cells; Eplerenone; Fibroblasts; Fibrosis; Humans; Kidney; Losartan; Male; Mannitol; Mineralocorticoid Receptor Antagonists; Proto-Oncogene Proteins c-sis; Ramipril; Rats, Wistar; Renin-Angiotensin System; Spironolactone | 2019 |
Antidepressant effect in diabetes-associated depression: A novel potential of RAAS inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antidepressive Agents; Antihypertensive Agents; Behavior, Animal; Blood Pressure; Depression; Diabetes Mellitus, Experimental; Disease Models, Animal; Down-Regulation; Enalapril; Eplerenone; Male; Mineralocorticoid Receptor Antagonists; Ramipril; Rats; Rats, Wistar; Renin-Angiotensin System; Spironolactone | 2020 |
Medicine-Induced Acute Kidney Injury Findings from Spontaneous Reporting Systems, Sequence Symmetry Analysis and a Case-Control Study with a Focus on Medicines Used in Primary Care.
Topics: Acute Kidney Injury; Adverse Drug Reaction Reporting Systems; Amlodipine; Amphotericin B; Australia; Case-Control Studies; Ciprofloxacin; Diclofenac; Furosemide; Humans; Ibuprofen; Metformin; Naproxen; Omeprazole; Primary Health Care; Ramipril; Simvastatin; Spironolactone; Sulfamethoxazole; Telmisartan; Trimethoprim; Valacyclovir; Zoledronic Acid | 2022 |
Effect of pharmacological heart failure drugs and gene therapy on Danon's cardiomyopathy.
Topics: Angiotensin II; Animals; Cardiomegaly; Fibrosis; Genetic Therapy; Glycogen Storage Disease Type IIb; Heart Failure; Humans; Mice; Ramipril; Reactive Oxygen Species; Spironolactone | 2023 |